NASDAQ:UPI - Uroplasty Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$1.22
Today's RangeN/A
52-Week Range$1.05 - $4.05
VolumeN/A
Average Volume124,964 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cogentix Medical, Inc. (Cogentix Medical) is a medical device company. The Company is engaged in the design, development, manufacturing and marketing of products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, known as EndoSheath technology, providing users with endoscope turnover. The Company's products include Urgent PC Neuromodulation System, Macroplastique Bulking Agent, Endoscopy Systems and EndoSheath Technology. The Company is also engaged in the commercialization of the Urgent PC Neuromodulation System, a device which delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). Its Macroplastique is an injectable soft-tissue bulking agent used to treat stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD). The Company offers 5000 and 7000 series of endoscopes, which are video endoscopy systems.

Receive UPI News and Ratings via Email

Sign-up to receive the latest news and ratings for UPI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:UPI
CUSIPN/A
Phone+1-952-4266140

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Uroplasty (NASDAQ:UPI) Frequently Asked Questions

What is Uroplasty's stock symbol?

Uroplasty trades on the NASDAQ under the ticker symbol "UPI."

Has Uroplasty been receiving favorable news coverage?

Press coverage about UPI stock has trended somewhat positive recently, according to InfoTrie. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Uroplasty earned a coverage optimism score of 0.9 on InfoTrie's scale. They also gave news coverage about the medical device company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of Uroplasty?

Shares of UPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Uroplasty's official website?

The official website for Uroplasty is http://www.uroplasty.com/.

How can I contact Uroplasty?

Uroplasty's mailing address is 5420 Feltl Road, MINNETONKA, MN 55343, United States. The medical device company can be reached via phone at +1-952-4266140.


MarketBeat Community Rating for Uroplasty (NASDAQ UPI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  100 (Vote Outperform)
Underperform Votes:  97 (Vote Underperform)
Total Votes:  197
MarketBeat's community ratings are surveys of what our community members think about Uroplasty and other stocks. Vote "Outperform" if you believe UPI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UPI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel